You can read the full article atYou can read the full article at Efficacy and safety of once-weekly semaglutide versus once-daily sitagliptin as add-on to metformin in patients with type 2 diabetes in SUSTAIN China: A 30-week, double-blind, phase 3a, randomized trial Due to increased obesity and inactivity rates, type 2 diabetes (T2D) is a complex, multifaceted disease with a rising prevalence rate
Achieve and Maintain a Healthy Weight Its no secret that most people who begin intermittent fasting do so to begin losing weight, or with the goal of reaching and maintaining a healthy weight
In Australia, we're fortunate in the sense that it's pretty tightly regulated and hopefully that will remain to be the case, but there are concerns and there's ever evolving this landscape
With NAFLD affecting 2530% of the global population, up to 6070% of people with type 2 diabetes and almost all individuals with severe obesity [9, 10], an available pharmacotherapy for NAFLD is highly warranted
The Importance of Specialized Care When it comes to GLP-1 medications, getting the right care is just as important as getting the right prescription
doi:10.3945/ajcn.2010.29885
